Stocks Allergan Inc


  • Will Allergan Raise It's Guidance?

    David Pyott, Allergan chairman/CEO, discusses the company's earnings, and products in the big pharma pipeline, with Mad Money's Jim Cramer.

  • Allergan Grows on Product Strategy

    Mad Money host Jim Cramer explains why Allergan isn't about to fall off a patent cliff like so many other big pharma companies. David Pyott, Allergan chairman, president & CEO weighs in on the company's earnings.

  • Weighing the Cost of Obesity

    Making a case for lap-band surgery and discussing the benefits to patients and insurance companies, with David Pyott, Allergan CEO.

  • Allergan CEO Talks Earnings

    David Pyott, Allergan chairman & CEO, discusses earnings and the aesthetics business, including Botox.